Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies.
D000402:Airway Obstruction / Q000209:etiology; D000818:Animals; D000906:Antibodies / Q000032:analysis*; D000925:Anticoagulants / Q000032:analysis; D001379:Azathioprine / Q000627:therapeutic use; D001803:Blood Transfusion; D002417:Cattle / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use*; D006406:Hematoma / Q000209:etiology; D006467:Hemophilia A / Q000276:immunology*; D006470:Hemorrhage / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D013552:Swine / Q000276:immunology
D000906:Antibodies; D000925:Anticoagulants; D003520:Cyclophosphamide; D005169:Factor VIII; D001379:Azathioprine; D011241:Prednisone